Details of the Drug Formulations

General Information of Drug (ID: DM4ZBK6)

Drug Name
Fedratinib Drug Info
Synonyms TG101348
Indication
Disease Entry ICD 11 Status REF
Myelofibrosis 2A20.2 Approved [1]
Polycythemia vera 2A20.4 Approved [2]
Coronavirus Disease 2019 (COVID-19) 1D6Y Investigative [3]
Cross-matching ID
PubChem CID
16722836
ChEBI ID
CHEBI:91408
CAS Number
936091-26-8
TTD ID
D0G8BM
ACDINA ID
D01069

Full List of Drug Formulations Containing This Drug

Fedratinib 100 mg capsule
Company Formulation ID FDA Description
Celgene Corporation F23165 Silicified Microcrystalline Cellulose; Sodium Stearyl Fumarate; Gelatin; Red Iron Oxide; Titanium Dioxide; White Ink
------------------------------------------------------------------------------------

References

1 Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health Human Services. 2019
2 FDA Approved Drug Products from FDA Official Website. 2019. Application Number: (NDA) 212327
3 TH17 responses in cytokine storm of COVID-19: An emerging target of JAK2 inhibitor Fedratinib. J Microbiol Immunol Infect. 2020 Mar 11. pii: S1684-1182(20)30065-7.